注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
AC Immune SA 是一家位于瑞士的临床阶段生物制药公司。该公司专注于神经退行性疾病的精准医疗。它设计、发现和开发用于预防、诊断和治疗由错误折叠蛋白质引起的疾病的治疗和诊断产品。其SupraAntigen和Morphomer技术平台可创建抗体、小分子和疫苗,旨在解决广泛的神经退行性适应症,例如阿尔茨海默病 (AD)。该公司的管道包括九个治疗候选产品,其中五个在临床试验中,以及三个诊断候选产品。其主要候选产品是 Crenezumab,一种用于治疗阿尔茨海默病的人源化单克隆抗 Abeta 抗体。它与制药公司合作,包括 Roche/Genentech、Eli Lilly、Biogen、Janssen Pharmaceuticals、Nestle Institute of Health Sciences、Life Molecular Imaging(原名:Piramal Imaging)和 Essex Bio-Technology。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Andrea Pfeifer | 64 | 2003 | Co-Founder, CEO & Director |
Claude Nicolau | - | - | Member of Scientific Advisory Board |
M. Monsigny | - | - | Member of Scientific Advisory Board |
Alf E. A. Lindberg | 81 | - | Member of Scientific Advisory Board |
Fred Van Leuven | - | - | Member of Scientific Advisory Board |
E. M. Voisin Lestringant | - | - | Member of Scientific Advisory Board |
I. Rosenberg | - | - | Member of Scientific Advisory Board |
Detlev H. Riesner | 79 | 2004 | Member of Scientific Advisory Board |
Douglas Edward Williams | 65 | 2018 | Independent Non-Executive Chairman |
Pierre N. Tariot | - | - | Member of Clinical Advisory Board |
Werner Lanthaler | 55 | 2018 | Independent Non-Executive Director |
Lon S. Schneider | - | - | Member of Clinical Advisory Board |
Monica Shaw | 44 | 2021 | Independent Non-Executive Director |
Roy Twyman | 66 | 2019 | Independent Non-Executive Director |
Juan Fortea | - | 2020 | Member of Clinical Advisory Board |
Carl H. June | 69 | 2020 | Independent Non-Executive Director |
Reisa Sperling | - | - | Member of Clinical Advisory Board |
Murat Emre | - | - | Member of Clinical Advisory Board |
Jean-Marie Pierre Lehn | 85 | - | Chairman of Scientific Advisory Board |
Monika Butler | 63 | 2021 | Independent Vice Chair |
Andreas Monsch | - | - | Head of Clinical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核